Search Results - "WAGNER, LASZLO"
-
1
SGLT2 inhibitor dapagliflozin prevents atherosclerotic and cardiac complications in experimental type 1 diabetes
Published in PloS one (17-02-2022)“…Cardiovascular disease (CVD) is two to five times more prevalent in diabetic patients and is the leading cause of death. Therefore, identification of novel…”
Get full text
Journal Article -
2
The Sigma-1 Receptor Is a Novel Target for Improving Cold Preservation in Rodent Kidney Transplants
Published in International journal of molecular sciences (01-07-2023)“…Kidney transplantation is the preferred treatment for patients with end-stage kidney disease. Maintaining organ viability between donation and transplantation,…”
Get full text
Journal Article -
3
RAAS inhibitors directly reduce diabetes‐induced renal fibrosis via growth factor inhibition
Published in The Journal of physiology (01-01-2019)“…Key points Increased activation of the renin‐angiotensin‐aldosterone system (RAAS) and elevated growth factor production are of crucial importance in the…”
Get full text
Journal Article -
4
Reduced O -GlcNAcylation and tubular hypoxia contribute to the antifibrotic effect of SGLT2 inhibitor dapagliflozin in the diabetic kidney
Published in American journal of physiology. Renal physiology (01-04-2020)“…Diabetic kidney disease is a worldwide epidemic, and therapies are incomplete. Clinical data suggest that improved renal outcomes by Na -glucose cotransporter…”
Get more information
Journal Article -
5
Cardioprotective and Antifibrotic Effects of Low-Dose Renin-Angiotensin-Aldosterone System Inhibitors in Type 1 Diabetic Rat Model
Published in International journal of molecular sciences (01-12-2023)“…Diabetic cardiovascular complications are associated with up to 50% mortality, and current therapies are not effective enough. Renin-angiotensin-aldosterone…”
Get full text
Journal Article -
6
An Overview of the Cardioprotective Effects of Novel Antidiabetic Classes: Focus on Inflammation, Oxidative Stress, and Fibrosis
Published in International journal of molecular sciences (24-04-2023)“…Metabolic diseases, particularly diabetes mellitus (DM), are significant global public health concerns. Despite the widespread use of standard-of-care…”
Get full text
Journal Article -
7
Long-term risks after kidney donation: how do we inform potential donors? A survey from DESCARTES and EKITA transplantation working groups
Published in Nephrology, dialysis, transplantation (15-02-2021)“…Abstract Background Publications from the last decade have increased knowledge regarding long-term risks after kidney donation. We wanted to perform a survey…”
Get full text
Journal Article -
8
Aldosterone antagonists in monotherapy are protective against streptozotocin-induced diabetic nephropathy in rats
Published in PloS one (28-06-2012)“…Angiotensin converting enzyme inhibitors (ACEi) and angiotensin II receptor blockers (ARB) are the standard clinical therapy of diabetic nephropathy (DN),…”
Get full text
Journal Article -
9
The role of sigma-1 receptor and brain-derived neurotrophic factor in the development of diabetes and comorbid depression in streptozotocin-induced diabetic rats
Published in Psychopharmacology (01-04-2016)“…Rationale Depression is highly prevalent in diabetes (DM). Brain-derived neurotrophic factor (BDNF) which is mainly regulated by the endoplasmic reticulum…”
Get full text
Journal Article -
10
Sexual dimorphism in the aging kidney: Effects on injury and nitric oxide system
Published in Kidney international (01-03-2003)“…Sexual dimorphism in the aging kidney: Effects on injury and nitric oxide system. Male gender confers enhanced susceptibility to development of age-dependent…”
Get full text
Journal Article -
11
Na+,K+-ATPase is modulated by angiotensin II in diabetic rat kidney â another reason for diabetic nephropathy?
Published in The Journal of physiology (15-11-2008)“…Angiotensin II (ANGII) plays a central role in the enhanced sodium reabsorption in early type 1 diabetes in man and in streptozotocin-induced (STZ) diabetic…”
Get full text
Journal Article -
12
Renal neuronal nitric oxide synthase protein expression as a marker of renal injury
Published in Kidney international (01-11-2003)“…Renal neuronal nitric oxide synthase protein expression as a marker of renal injury. Animal studies suggest that nitric oxide deficiency occurs in the remnant…”
Get full text
Journal Article -
13
Oncological Screening of Kidney Transplant Patients: The Role of Ultrasound Examination
Published in Transplantation proceedings (01-05-2019)“…Immunosuppressive therapy used after organ transplantation represents a considerable oncological risk. Abdominal ultrasound examinations play an essential role…”
Get full text
Journal Article -
14
Case report: COVID-19 infection in a pregnant 33-year-old kidney transplant recipient
Published in Frontiers in medicine (30-08-2022)“…Patients facing severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) infections with comorbidities, especially patients whose immune system is weakened…”
Get full text
Journal Article -
15
3105 Tocilizumab for treatment of antibody mediated rejection in kidney transplant patients
Published in Nephrology, dialysis, transplantation (23-05-2024)Get full text
Journal Article -
16
Genetic analysis and functional characterization of novel mutations in a series of patients with atypical hemolytic uremic syndrome
Published in Molecular immunology (01-03-2016)“…•30 aHUS patients and their family members were included in this study.•We identified 27 (12 novel) potentially disease-causing mutations in the genes CFH,…”
Get full text
Journal Article -
17
MO1019: Sigma-1 Receptor Agonists are Protective in a Rat Model of Kidney Transplantation
Published in Nephrology, dialysis, transplantation (03-05-2022)Get full text
Journal Article -
18
NPHS2 homozygous p.R229Q variant: potential modifier instead of causal effect in focal segmental glomerulosclerosis
Published in Pediatric nephrology (Berlin, West) (01-10-2013)“…Background The pathogenicity of the NPHS2 homozygous p.R229Q variant in steroid-resistant nephrotic syndrome (SRNS) is doubtful. While it has been reported in…”
Get full text
Journal Article -
19
Low-Dose vs Standard-Dose Valganciclovir for Cytomegalovirus Prophylaxis After Kidney Transplantation: A Single-Center Retrospective Analysis
Published in Transplantation proceedings (01-01-2024)“…Prophylactic administration of valganciclovir (VG) is an accepted method for the prevention of cytomegalovirus (CMV) infection after kidney transplantation…”
Get full text
Journal Article -
20
MO282: Sigma-1 Receptor Agonists are Protective in Renal Ischemia/Reperfusion Injury
Published in Nephrology, dialysis, transplantation (03-05-2022)Get full text
Journal Article